Select Your Language...  


TURKISH     ENGLISH     FRENCH     GERMANY     SPANISH     ITALIAN     DANISH     SWEDISH

Hepatitis C Vaccine | Hepatitis

Search

Ads

Categories

Recent Posts

Popular Search Terms

Random Search Terms

Tags

Sitemap

Archives

Hepatitis A infection is caused by the hepatitis A virus (HAV).

When infected by hepatitis A virus, adolescents and adults are more inclined than young kids to develop indications of disease, including fever, weakness, nausea, abdominal pain, dark urine, and yellow eyes and skin, and are more likely to experience severe disease.

Symptoms usually last under two months, but 10% to 15% of these infected may have prolonged or relapsing disease lasting as much as six months. Unlike hepatitis B and C, chronic hepatitis A disease does not occur. Unfortunately, every year within the U.S. 125,000 to 200,000 people become sick with hepatitis A. In the united states, 70 to 100 people die? mostly those with underlying liver disease.

Most hepatitis A illness happens in community-wide outbreaks. Herpes virus is most often spread in stool, although it could be spread through connection with infected blood. Infection is transmitted from person to person in households and relatives settings. Outbreaks sometimes occur when many people have eaten from the same hepatitis A-infected meal source but nearly half of individuals have no identified risk factor. Infected people are probably to spread hepatitis A virus throughout the two-week period before they are fully aware they’re infected. Since most infected pre-school children show no the signs of hepatitis A infection, they frequently unknowingly distribute the hepatitis A virus to others.

Before the introduction of  hepatitis A, about one-third from the hepatitis A cases in the U.S. occurred in children 5 to 14 years old. The lowest rate of infection is at adults a lot more than 40 years old. The rates of infection and disease were much greater in some areas of the country than the others.

hepatitis a vaccine Hepatitis A Vaccine

hepatitis a vaccine side effects, hepatitis a vaccine price, hepatitis b vaccine, hepatitis c, typhoid vaccine, hepatitis c vaccine, hepatitis a vaccine brand name, hepatitis a vaccine ingredients

Hepatitis A virus (HAV) is an RNA virus of a single serotype. Infection usually causes clinical hepatitis in adults and school-aged children but is often asymptomatic in younger children. Jaundice develops in < 10% of children 6 years and under. Typical symptoms of illness include anorexia, nausea, fatigue, fever and jaundice. The severity of the illness increases with age. Recovery often takes 4 to 6 weeks but may take months. Recurrent hepatitis for up to a year occurs in about 15% of cases, but longer chronic infection is not known to occur. About 25% of reported adult cases require hospitalization. Fulminant disease with liver necrosis is rare but can be fatal. Individuals with pre-existing chronic liver disease are at increased risk of serious complications from HAV infection. The overall estimated case fatality rate associated with hepatitis A is 0.1% to 0.3%, but this rises to 1.8% in persons over the age of 50. It reaches 12.5% in patients over the age of 60 who are hospitalized due to the disease.

Since the publication of the 2002 Canadian Immunization Guide, new data happen to be obtained on the epidemiology of hepatitis A in Canada as well as on the immunization coverage of travellers to endemic countries.

Hepatitis A virus (HAV) is an RNA virus of merely one serotype. Infection usually causes clinical hepatitis in adults and school-aged children but is often asymptomatic in younger children. Jaundice develops in < 10Percent of kids 6 many under. Typical symptoms of illness include anorexia, nausea, fatigue, fever and jaundice. The seriousness of the illness increases with age. Recovery normally takes four to six weeks but might take months. Recurrent hepatitis for up to a year occurs in about 15% of cases, but longer chronic infection isn’t recognized to occur. About 25% of reported adult cases require hospitalization. Fulminant disease with liver necrosis is rare but can be fatal. Individuals with pre-existing chronic liver disease are at increased risk of serious complications from HAV infection. The entire estimated case fatality rate related to hepatitis A is 0.1% to 0.3%, but this rises to 1.8% in persons older than 50. It reaches 12.5% in patients over the age of 60 who’re hospitalized due to the disease.

Because the publication of the 2002 Canadian Immunization Guide, new data happen to be obtained on the epidemiology of hepatitis A in Canada as well as on the immunization coverage of travellers to endemic countries.

HAV is most often transmitted through the fecal-oral route, through direct contact with infected people or indirectly through ingestion of contaminated water or foods. On rare occasions, transmission continues to be reported after contact with HAV-contaminated blood or blood products. It also occurs through sexual activities that include direct or indirect oro-anal contact although not through exposure to saliva, semen or urine. The virus may persist for days or weeks in the environment. Shedding of the virus in feces and thus maximum infectiousness occurs throughout the latter part of the incubation period with peak levels within the 2 weeks before clinical illness. Infectiousness diminishes rapidly thereafter and ends shortly after the start of jaundice. Humans are the principal reservoir for HAV. Persistent infection does not occur. The incubation period ranges from 15 to 50 days with an average of 20 to 30 days. Lifelong immunity usually follows infection.

In Canada, between 1990 and 2004 the amount of cases of HAV infection reported annually varied from 3,562 (1991) to 396 (2003), representing rates of 10.8 and 1.2 per 100,000 population respectively. Throughout this era, there has been outbreaks involving men that have relations with men  in main Canadian cities. Because the introduction of the vaccine in 1996, no new major outbreak has occurred, and the incidence rate has slowly decreased. It is not known whether this really is due to the impact of the targeted immunization programs. There is no info on the proportion of targeted groups being immunized, but it’s likely low. The estimated coverage in MSM after the huge immunization campaign during the Montreal outbreak was only 35%. Within Canada, there have been considerable geographic variations within the reported incidence, and this is observed even during periods of decline nationally. In the 5 year period of 1999 to 2004, no substantial sex difference in reported rates was observed. In 2004, the reported rate was 1.4 among females and 1.6 among males per 100,000 population. Age-specific incidence was highest among those 15-24 years old with a rate of 2.3 per 100,000 population, followed closely by those aged 5-14.

Incoming search terms:

Recent searches for this post: chicken pox vaccine booster chicken pox vaccine cost h1n1 vaccine side effects hepatitis A symptoms hepatitis a vaccine adverse effects hepatitis a vaccine brand name hepatitis a vaccine ingredients hepatitis a vaccine price hepatitis a vaccine recommendations hepatitis a vaccine schedule children hepatitis a vaccine schedule for adults hepatitis a vaccine side effects hepatitis a vaccine side effects rash hepatitis b vaccine hepatitis b vaccine booster hepatitis b vaccine schedule hepatitis b vaccine schedule for adults hepatitis b vaccine side effects Hepatitis C hepatitis c cost hepatitis c vaccine hepatitis vaccine immunity immunization prices meningitis vaccine booster meningitis vaccine cost polio vaccine cost reactions to hep a vaccine tetanus shot side effects tetanus vaccine booster twinrix booster typhoid vaccine typhoid vaccine booster typhoid vaccine cost typhoid vaccine schedule typhoid vaccine side effects varicella vaccine booster yellow fever vaccine booster yellow fever vaccine cost yellow fever vaccine side effects